The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8633196, 21 ID: ALA3648904
Chembl Id: CHEMBL3648904
PubChem CID: 49847597
Max Phase: Preclinical
Molecular Formula: C32H37N5O5S
Molecular Weight: 603.75
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(CN2CCN([C@@H](CNS(=O)(=O)c3ccc(OCc4cc(C)nc5ccccc45)cc3)C(=O)NO)CC2)cc1
Standard InChI: InChI=1S/C32H37N5O5S/c1-23-7-9-25(10-8-23)21-36-15-17-37(18-16-36)31(32(38)35-39)20-33-43(40,41)28-13-11-27(12-14-28)42-22-26-19-24(2)34-30-6-4-3-5-29(26)30/h3-14,19,31,33,39H,15-18,20-22H2,1-2H3,(H,35,38)/t31-/m0/s1
Standard InChI Key: OEKBBQNVZPGHFU-HKBQPEDESA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 603.75Molecular Weight (Monoisotopic): 603.2515AlogP: 3.40#Rotatable Bonds: 11Polar Surface Area: 124.10Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.71CX Basic pKa: 7.05CX LogP: 3.52CX LogD: 3.46Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.18Np Likeness Score: -1.39
References 1. (2014) Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics, 2. (2016) Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics,